All In MedTech

Device Trial Radar · NCT03012841

STOP Persistent AF

Last checked: Nov 19, 2026Latest source record: Feb 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

186

Actual

Start

Mar 2, 2017

Primary completion

Aug 13, 2019

Study completion Aug 13, 2019

Sponsor

Lead sponsor
Medtronic Cardiac Ablation SolutionsPublic (MDT)
Sponsor type
Industry
First posted
Jan 6, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of drug refractory recurrent symptomatic persistent atrial fibrillation (AF).

Conditions

  • Atrial Fibrillation

Interventions

  • Arctic Front Advance Cardiac CryoAblation CatheterDevice

    Cryoablation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects Free From Treatment Failure at 12 Months After the Pulmonary Vein Isolation (PVI) Ablation Procedure.Time frame: 12 Months
  2. Percent of Subjects Free From a Primary Safety Event at 12 Months After the Pulmonary Vein Isolation (PVI) Ablation Procedure.Time frame: 12 months

Locations

25 sites in 3 countries. Site status is shown where the registry gives one.

  • Banner-University Medical Center Phoenix

    Phoenix, Arizona

  • Colorado Heart and Vascular

    Lakewood, Colorado

  • Medical Center of the Rockies

    Loveland, Colorado

22 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.